MA55083A - Polyribonucléotides et leurs utilisations cosmétiques - Google Patents

Polyribonucléotides et leurs utilisations cosmétiques

Info

Publication number
MA55083A
MA55083A MA055083A MA55083A MA55083A MA 55083 A MA55083 A MA 55083A MA 055083 A MA055083 A MA 055083A MA 55083 A MA55083 A MA 55083A MA 55083 A MA55083 A MA 55083A
Authority
MA
Morocco
Prior art keywords
polyribonucleotides
cosmetic uses
cosmetic
Prior art date
Application number
MA055083A
Other languages
English (en)
Inventor
Ellese Marie Carmona
Boer Alexandra Sophie De
Avak Kahvejian
Nicholas Mccartney Plugis
Morag Helen Stewart
Original Assignee
Flagship Pioneering Innovations Vi Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations Vi Llc filed Critical Flagship Pioneering Innovations Vi Llc
Publication of MA55083A publication Critical patent/MA55083A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D37/00—Sachet pads specially adapted for liquid toiletry or cosmetic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D2200/00—Details not otherwise provided for in A45D
    • A45D2200/10—Details of applicators
    • A45D2200/1009—Applicators comprising a pad, tissue, sponge, or the like
    • A45D2200/1018—Applicators comprising a pad, tissue, sponge, or the like comprising a pad, i.e. a cushion-like mass of soft material, with or without gripping means
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D2200/00—Details not otherwise provided for in A45D
    • A45D2200/25—Kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA055083A 2019-03-01 2020-03-01 Polyribonucléotides et leurs utilisations cosmétiques MA55083A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962812772P 2019-03-01 2019-03-01

Publications (1)

Publication Number Publication Date
MA55083A true MA55083A (fr) 2022-03-16

Family

ID=70050204

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055083A MA55083A (fr) 2019-03-01 2020-03-01 Polyribonucléotides et leurs utilisations cosmétiques

Country Status (13)

Country Link
US (1) US20220142896A1 (fr)
EP (1) EP3930676B1 (fr)
JP (1) JP2022522768A (fr)
KR (1) KR20210135529A (fr)
CN (1) CN113543766A (fr)
AU (1) AU2020232238A1 (fr)
CA (1) CA3128644A1 (fr)
DK (1) DK3930676T3 (fr)
ES (1) ES2928724T3 (fr)
IL (2) IL311628A (fr)
MA (1) MA55083A (fr)
PL (1) PL3930676T3 (fr)
WO (1) WO2020180752A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020011670A2 (pt) 2017-12-15 2020-11-17 Flagship Pioneering Innovations Vi, Llc. composições compreendendo polirribonucleotídeos circulares e seus usos
US11484077B1 (en) * 2019-10-08 2022-11-01 Mea Madamba Arsenault Combination storage and sterilization device for fake eyelashes
CN112481289B (zh) 2020-12-04 2023-06-27 苏州科锐迈德生物医药科技有限公司 一种转录环状rna的重组核酸分子及其在蛋白表达中的应用
CA3202885A1 (fr) * 2020-12-31 2022-07-07 Michael Nghiem Le Bassin contenant des produits de spa emballes individuellement et destines a etre utilises avec celui-ci
AU2022397292A1 (en) 2021-11-24 2024-05-30 Flagship Pioneering Innovations Vi, Llc Varicella-zoster virus immunogen compositions and their uses
WO2023096990A1 (fr) 2021-11-24 2023-06-01 Flagship Pioneering Innovation Vi, Llc Compositions immunogènes de coronavirus et leurs utilisations
WO2023097003A2 (fr) 2021-11-24 2023-06-01 Flagship Pioneering Innovations Vi, Llc Compositions immunogènes et leurs utilisations
TW202340460A (zh) 2021-12-17 2023-10-16 美商旗艦先鋒創新有限責任公司 用於在變性條件下富集環狀ｒｎａ之方法
TW202342064A (zh) 2021-12-23 2023-11-01 美商旗艦先鋒創新有限責任公司 編碼抗融合多肽之環狀多核糖核苷酸

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2796990B2 (ja) 1989-05-10 1998-09-10 株式会社資生堂 肌用化粧料
WO1992001813A1 (fr) 1990-07-25 1992-02-06 Syngene, Inc. Extension circulaire pour generer plusieurs copies complementaires d'un acide nucleique
US5426180A (en) 1991-03-27 1995-06-20 Research Corporation Technologies, Inc. Methods of making single-stranded circular oligonucleotides
US5877160A (en) * 1991-05-31 1999-03-02 Genta Incorporated Compositions and methods of treatment of androgen-associated baldness using antisense oligomers
WO1993014218A1 (fr) 1992-01-13 1993-07-22 Duke University Molecules d'arn enzymatiques
US5773244A (en) 1993-05-19 1998-06-30 Regents Of The University Of California Methods of making circular RNA
US5766903A (en) 1995-08-23 1998-06-16 University Technology Corporation Circular RNA and uses thereof
US6210931B1 (en) 1998-11-30 2001-04-03 The United States Of America As Represented By The Secretary Of Agriculture Ribozyme-mediated synthesis of circular RNA
DE102004025881A1 (de) * 2004-05-19 2006-01-05 Beiersdorf Ag Oligoribonukleotide zur Beeinflussung des Haarwachstums
DE102005001784A1 (de) * 2005-01-13 2006-10-05 Beiersdorf Ag Oligoribonukleotide zur Reduktion der Schweißbildung durch RNA-Interferenz
FR2885808B1 (fr) * 2005-05-19 2007-07-06 Oreal Vectorisation de dsrna par des particules cationiques et utilisation topique.
DE102005046490A1 (de) 2005-09-28 2007-03-29 Johannes-Gutenberg-Universität Mainz Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
JP2009519033A (ja) 2005-12-16 2009-05-14 ディアト 核酸を細胞に送達するための細胞貫通ペプチド結合体
US20100168034A1 (en) 2006-02-20 2010-07-01 Ewha University-Industry Collaboration Foundation Peptide having cell membrane penetrating activity
JP5296328B2 (ja) 2007-05-09 2013-09-25 独立行政法人理化学研究所 １本鎖環状ｒｎａおよびその製造方法
WO2010084371A1 (fr) 2009-01-26 2010-07-29 Mitoprod Nouvelles molécules d'arn interférent circulaire
NZ704191A (en) 2010-06-14 2016-05-27 Hoffmann La Roche Cell-penetrating peptides and uses therof
HRP20220695T1 (hr) 2010-08-31 2022-07-08 Glaxosmithkline Biologicals Sa Pegilirani liposomi za isporuku rnk kodirane za imunogen
KR101938548B1 (ko) * 2011-06-23 2019-01-15 (주)아모레퍼시픽 마이크로 ｒｎａ를 포함하는 색소형성유전자 발현조절용 조성물
RU2014104090A (ru) 2011-07-06 2015-08-20 Новартис Аг Липосомы с эффективным соотношением n:p для доставки молекул phk
EP2765982A1 (fr) * 2011-10-11 2014-08-20 Hans Kosak Diméthylsulfoxyde utilisé comme solvant pour des acides nucléiques
DE102013005361A1 (de) * 2013-03-28 2014-10-02 Eberhard Karls Universität Tübingen Medizinische Fakultät Polyribonucleotid
WO2016036735A1 (fr) 2014-09-05 2016-03-10 The Johns Hopkins University Particules pénétrant à travers le mucus, à base de liposomes, pour une administration par voie muqueuse
AU2016236521B2 (en) * 2015-03-20 2019-03-07 Unilever Global Ip Limited Antiperspirant composition
JP7317706B2 (ja) 2016-12-14 2023-07-31 リガンダル インコーポレイテッド 核酸およびタンパク質ペイロード送達のための方法および組成物

Also Published As

Publication number Publication date
JP2022522768A (ja) 2022-04-20
CA3128644A1 (fr) 2020-09-10
CN113543766A (zh) 2021-10-22
KR20210135529A (ko) 2021-11-15
IL285951A (en) 2021-10-31
EP3930676B1 (fr) 2022-08-03
ES2928724T3 (es) 2022-11-22
AU2020232238A1 (en) 2021-09-23
PL3930676T3 (pl) 2023-01-23
US20220142896A1 (en) 2022-05-12
WO2020180752A1 (fr) 2020-09-10
DK3930676T3 (en) 2022-10-31
IL311628A (en) 2024-05-01
IL285951B1 (en) 2024-04-01
EP3930676A1 (fr) 2022-01-05

Similar Documents

Publication Publication Date Title
MA55083A (fr) Polyribonucléotides et leurs utilisations cosmétiques
MA50618A (fr) Polyrhérapies et leurs utilisations
MA47789A (fr) Anticorps anti-phf-tau et leurs utilisations
MA49971A (fr) Vésicules extracellulaires modifiées et leurs utilisations
MA51155A (fr) Compositions comprenant des polyribonucléotides circulaires et leurs utilisations
MA50256A (fr) Composés de pyrazolopyrimidinone et leurs utilisations
MA50502A (fr) Adénovirus et utilisations associées
MA49683A (fr) Anticorps anti-cd8 et leurs utilisations
MA49537A (fr) Anticorps anti-lag3 et leurs utilisations
MA52426A (fr) Conjugués d'il-15 et leurs utilisations
MA53184A (fr) Anticorps anti-ox40 et leurs utilisations
MA51288A (fr) Analogues d'incrétine et leurs utilisations
MA50397A (fr) Anticorps anti-tau et leurs utilisations
MA49687A (fr) Anticorps anti-ctla-4 et leurs utilisations
MA45125A (fr) Anticorps anti-alpha-synucléine et leurs utilisations
MA49886A (fr) Anticorps anti-par2 et leurs utilisations
MA51287A (fr) Analogues d'incrétine et leurs utilisations
MA50265A (fr) Conjugués anticorps-récepteur alpha anti-folate et leurs utilisations
MA43821A (fr) Pyrimidines et variantes de celles-ci, et leurs utilisations
MA48861A (fr) Améliorations pharmacocinétiques de chélates bifonctionnels et leurs utilisations
MA45233A (fr) Anticorps anti-gitr et leurs utilisations
MA43567A (fr) Anticorps pacap et leurs utilisations
MA46704A (fr) Anticorps anti-pyroglutamate- amyloïde-beta et leurs utilisations
MA46945A (fr) Exopolysaccharides et leurs utilisations
MA44489A (fr) Pyrimidines et variants de celles-ci, et leurs utilisations